Angelman syndrome

The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.

BioArray Briefs

Premium

Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen

Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases.

Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.